Technical Analysis for AKBA - Akebia Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.88% | |
| BB Squeeze Ended | Range Expansion | 0.88% | |
| Below Lower BB | Weakness | 0.88% | |
| Down 3 Days in a Row | Weakness | 0.88% | |
| Lower Bollinger Band Touch | Weakness | 0.88% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 5 hours ago |
| Up 3% | about 5 hours ago |
| Up 2% | about 6 hours ago |
| Up 1% | about 6 hours ago |
| 60 Minute Opening Range Breakout | about 6 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/06/2024
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Kidney Disease Dialysis Anemia Chronic Kidney Disease Kidney Hypoxia Inducible Factors
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.48 |
| 52 Week Low | 0.7801 |
| Average Volume | 5,744,920 |
| 200-Day Moving Average | 1.31 |
| 50-Day Moving Average | 1.50 |
| 20-Day Moving Average | 1.29 |
| 10-Day Moving Average | 1.25 |
| Average True Range | 0.12 |
| RSI (14) | 36.31 |
| ADX | 25.0 |
| +DI | 13.94 |
| -DI | 27.67 |
| Chandelier Exit (Long, 3 ATRs) | 1.21 |
| Chandelier Exit (Short, 3 ATRs) | 1.38 |
| Upper Bollinger Bands | 1.48 |
| Lower Bollinger Band | 1.11 |
| Percent B (%b) | 0.12 |
| BandWidth | 29.10 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0108 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.27 | ||||
| Resistance 3 (R3) | 1.27 | 1.24 | 1.25 | ||
| Resistance 2 (R2) | 1.24 | 1.21 | 1.24 | 1.24 | |
| Resistance 1 (R1) | 1.19 | 1.19 | 1.22 | 1.19 | 1.24 |
| Pivot Point | 1.16 | 1.16 | 1.17 | 1.16 | 1.16 |
| Support 1 (S1) | 1.11 | 1.13 | 1.14 | 1.11 | 1.06 |
| Support 2 (S2) | 1.08 | 1.11 | 1.08 | 1.06 | |
| Support 3 (S3) | 1.03 | 1.08 | 1.05 | ||
| Support 4 (S4) | 1.03 |
